Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isoxsuprine (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Cyclandelate poisoning (disorder) |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Peripheral/cerebral vasodilator poisoning |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
1 |
Peripheral/cerebral vasodilator adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
1 |
Bamethan sulfate adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Oxpentifylline adverse reaction (disorder) |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Cyclandelate adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Nicofuranose adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Inositol nicotinate adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Naftidrofuryl adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Nicotinyl alcohol adverse reaction |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Peripheral/cerebral vasodilator allergy |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Bamethan sulfate allergy |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Allergy to pentoxifylline (finding) |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Allergy to cyclandelate (finding) |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Allergy to nicofuranose |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Inositol nicotinate allergy |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Allergy to nafronyl |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Allergy to nicotinyl alcohol (finding) |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Peripheral/cerebral vasodilator overdose |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
1 |
Bamethan sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Inositol nicotinate 200 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Other drugs for peripheral vascular disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing iloprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Iloprost 100micrograms/mL infusion concentrate 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Naftidrofuryl oxalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing precisely naftidrofuryl oxalate 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing nicofuranose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Peripheral/cerebral vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing inositol niacinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing naftidrofuryl (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing nicotinyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Bamethan sulfate (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing cyclandelate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Iloprost 10mcg/mL nebulizer solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Inositol nicotinate |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Cyclandelate (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Pentoxifylline (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Nicofuranose (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Naftidrofuryl |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Nicotinyl alcohol (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Iloprost 10mcg/mL nebulizer solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Peripheral/cerebral vasodilator allergy |
Causative agent (attribute) |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
1 |
Vinburnine |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Vincamine |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Bamethan |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Buflomedil |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing iloprost in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Product containing iloprost in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Ifenprodil (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Isoxsuprine hydrochloride |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Naftidrofuryl oxalate (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Inositol |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|
Diazoxide (substance) |
Is a |
False |
Peripheral/cerebral vasodilator |
Inferred relationship |
Some |
|